Search research articles
Contact Us
Filters
Showing results (301-310 of 320) with videos related to
Page
of 32
Sort By:
Frontiers in Pharmacology
|
April 27, 2026
Oral 18-methoxycoronaridine activity in simian and murine <i>Leishmania amazonensis</i> infection
J C Delorenzi, T S Melo, F T Silveira, et al.
Plos One
|
April 22, 2021
High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity
Ryan Choi, Mowei Zhou, Roger Shek, et al.
Scientific Reports
|
October 19, 2021
Visible blue light inhibits infection and replication of SARS-CoV-2 at doses that are well-tolerated by human respiratory tissue
Nathan Stasko, Jacob F Kocher, Abigail Annas, et al.
Nature Communications
|
February 14, 2026
From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum
Kaustav Khatua, Sandeep Atla, Demonta Coleman, et al.
ACS Infectious Diseases
|
December 18, 2025
Broad-Spectrum Peptidomimetic Inhibitors of Norovirus and Coronavirus 3C-like Proteases
Margaret A Brimble, Louise A Stubbing, Yann O Hermant, et al.
ACS Omega
|
September 13, 2022
Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice
Ana C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Biorxiv : the Preprint Server for Biology
|
January 4, 2022
Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected Mice
Ana C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Biorxiv : the Preprint Server for Biology
|
August 20, 2025
Structure-Activity Relationship Studies Towards Analogues of Pleconaril as Novel Enterovirus-D68 Capsid-Targeting Antivirals
David L Cousins, Ed J Griffen, Jessica Stacey, et al.
Biorxiv : the Preprint Server for Biology
|
December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms
Ana C Puhl, Ethan James Fritch, Thomas R Lane, et al.
ACS Omega
|
March 29, 2021
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: <i>In Vitro</i> Activity against SARS-CoV-2 and Potential Mechanisms
Ana C Puhl, Ethan J Fritch, Thomas R Lane, et al.
Page
of 32
Search research articles
Search
Showing results (301-310 of 320) with videos related to
Sort By:
Page
of 32
Frontiers in Pharmacology
|
April 27, 2026
Oral 18-methoxycoronaridine activity in simian and murine <i>Leishmania amazonensis</i> infection
J C Delorenzi, T S Melo, F T Silveira, et al.
Plos One
|
April 22, 2021
High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity
Ryan Choi, Mowei Zhou, Roger Shek, et al.
Scientific Reports
|
October 19, 2021
Visible blue light inhibits infection and replication of SARS-CoV-2 at doses that are well-tolerated by human respiratory tissue
Nathan Stasko, Jacob F Kocher, Abigail Annas, et al.
Nature Communications
|
February 14, 2026
From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum
Kaustav Khatua, Sandeep Atla, Demonta Coleman, et al.
ACS Infectious Diseases
|
December 18, 2025
Broad-Spectrum Peptidomimetic Inhibitors of Norovirus and Coronavirus 3C-like Proteases
Margaret A Brimble, Louise A Stubbing, Yann O Hermant, et al.
ACS Omega
|
September 13, 2022
Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice
Ana C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Biorxiv : the Preprint Server for Biology
|
January 4, 2022
Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected Mice
Ana C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Biorxiv : the Preprint Server for Biology
|
August 20, 2025
Structure-Activity Relationship Studies Towards Analogues of Pleconaril as Novel Enterovirus-D68 Capsid-Targeting Antivirals
David L Cousins, Ed J Griffen, Jessica Stacey, et al.
Biorxiv : the Preprint Server for Biology
|
December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms
Ana C Puhl, Ethan James Fritch, Thomas R Lane, et al.
ACS Omega
|
March 29, 2021
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: <i>In Vitro</i> Activity against SARS-CoV-2 and Potential Mechanisms
Ana C Puhl, Ethan J Fritch, Thomas R Lane, et al.
Page
of 32